Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambria Investment Advisors is an independent investment management firm focused on quantitative asset management and the creation of exchange-traded funds (ETFs). Founded by Meb Faber and Eric Richardson, the firm is recognized for its research-driven approach to investing, particularly in areas such as shareholder yield, global value, and tactical asset allocation. Cambria manages a suite of ETFs designed to provide investors with low-cost access to sophisticated, rules-based investment strategies. While the firm may invest in healthcare and life sciences companies through its various funds, it is primarily a financial services entity rather than a biotechnology or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cambria Investment Advisors.